Check out the companies making headlines yesterday:

United Therapeutics (NASDAQ: UTHR): Biotechnology company United Therapeutics (NASDAQ: UTHR) rose by 13.6% on Wednesday after a federal district court ruled that competitor Liquidia Corporation infringed patent claims covering United Therapeutics' inhaled treprostinil treatments. See our full article here.

Is now the time to buy United Therapeutics? Access our full analysis report here, it’s free.

Moderna (NASDAQ: MRNA): Biotechnology company Moderna (NASDAQ: MRNA) fell by 6% on Wednesday after Citigroup downgraded the company to Sell from Neutral, warning that a 222% rally had pushed its valuation to unsustainable levels. See our full article here.

Is now the time to buy Moderna? Access our full analysis report here, it’s free.

Jabil (NYSE: JBL): Electronics manufacturing services provider Jabil (NYSE: JBL) fell by 6.5% on Wednesday after it reported fourth-quarter and fiscal 2026 results and issued a solid fiscal 2027 outlook. See our full article here.

Is now the time to buy Jabil? Access our full analysis report here, it’s free.

Concentrix (NASDAQ: CNXC): Customer experience solutions provider Concentrix (NASDAQ: CNXC) rose by 4% on Wednesday after the company reported a significant net loss for its third quarter, driven by a $1.5 billion non-cash goodwill impairment charge and declining revenue. See our full article here.

Is now the time to buy Concentrix? Access our full analysis report here, it’s free.

FactSet (NYSE: FDS): Financial data provider FactSet (NYSE: FDS) rose by 3.8% on Wednesday after the company reported calendar third-quarter 2026 revenue growth of 6.3% and issued fiscal 2027 financial targets. See our full article here.

Is now the time to buy FactSet? Access our full analysis report here, it’s free.